TY - JOUR
T1 - The course of glaucoma during pregnancy
T2 - A retrospective case series
AU - Brauner, Stacey C.
AU - Chen, Teresa C.
AU - Hutchinson, B. Thomas
AU - Chang, Michael A.
AU - Pasquale, Louis R.
AU - Grosskreutz, Cynthia L.
PY - 2006/8
Y1 - 2006/8
N2 - Objective: To better understand the course of glaucoma during pregnancy in women with preexisting disease. Methods: Retrospective case series of 28 eyes of 15 women with glaucoma followed up during pregnancy. Data were analyzed for age, race/ethnicity, medications, glaucoma type, intraocular pressure (IOP), and visual fields before, during, and after pregnancy. Results: In 16 (57.1%) of 28 eyes, IOP was stable during pregnancy, with no progression of visual field loss. In 5 eyes (17.9%), visual field loss progressed during pregnancy, while IOP remained stable or increased. In 5 eyes (17.9%), IOP increased during pregnancy, but there was no progression of visual field loss. In 2 eyes (7.1%), data were inconclusive because of medication noncompliance and preexisting severe visual field loss. Glaucoma medications were used by 13 of 15 patients to control glaucoma during pregnancy. The classes of medications used most frequently were β-blockers, α2-adrenergic agents, cholinergic agents, and topical carbonic anhydrase inhibitors. Conclusions: The course of glaucoma during pregnancy is variable, and women must be monitored closely during pregnancy. Medications may be necessary to control IOP and to prevent vision loss during pregnancy.
AB - Objective: To better understand the course of glaucoma during pregnancy in women with preexisting disease. Methods: Retrospective case series of 28 eyes of 15 women with glaucoma followed up during pregnancy. Data were analyzed for age, race/ethnicity, medications, glaucoma type, intraocular pressure (IOP), and visual fields before, during, and after pregnancy. Results: In 16 (57.1%) of 28 eyes, IOP was stable during pregnancy, with no progression of visual field loss. In 5 eyes (17.9%), visual field loss progressed during pregnancy, while IOP remained stable or increased. In 5 eyes (17.9%), IOP increased during pregnancy, but there was no progression of visual field loss. In 2 eyes (7.1%), data were inconclusive because of medication noncompliance and preexisting severe visual field loss. Glaucoma medications were used by 13 of 15 patients to control glaucoma during pregnancy. The classes of medications used most frequently were β-blockers, α2-adrenergic agents, cholinergic agents, and topical carbonic anhydrase inhibitors. Conclusions: The course of glaucoma during pregnancy is variable, and women must be monitored closely during pregnancy. Medications may be necessary to control IOP and to prevent vision loss during pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=33747184500&partnerID=8YFLogxK
U2 - 10.1001/archopht.124.8.1089
DO - 10.1001/archopht.124.8.1089
M3 - Article
C2 - 16908810
AN - SCOPUS:33747184500
SN - 0003-9950
VL - 124
SP - 1089
EP - 1094
JO - Archives of Ophthalmology
JF - Archives of Ophthalmology
IS - 8
ER -